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E-cigarette use and perceived health change: Better health
through vaping?
Joy L. Hart1,2, Kandi L. Walker1,2, Clara G. Sears1,2, Alexander S. Lee1,2, Stanley Lee Ridner3, Rachel J. Keith2,4

ABSTRACT
As e-cigarette use increases, questions about individual and public
health effects remain unanswered (e.g. cessation tool, addiction path). Despite
increasing use, few studies have focused on vape shop patrons. This study
examined whether vape shop patrons believe their health is affected by the use
of e-cigs; more specifically, the aim was to evaluate the association between e-cig
use, change in tobacco use, and perception of health.
METHODS A survey of e-cig users (N=78) was conducted in vape shops. Questions
included e-cig and traditional tobacco use, health perceptions, and demographics.
Descriptive techniques were used to characterize participants as either those
who perceived e-cig use improved their health or those who perceived their
health unaffected. Logistic regression assessed the association between change
in tobacco use, e-cig use, and perception of health effects.
RESULTS Most reported daily e-cig (91%) and current (11.5%) or former (78.2%)
combustible cigarette use. Approximately, three-fourths (76.9%) perceived
better health; the remainder (23.1%) perceived unaffected health. Change in
cigarette use was significantly associated with perceptions that health is better
with e-cig use. Participants who decreased cigarette use by 2–3 cartons/month
and more than 3 cartons/month were significantly more likely to indicate that
e-cig use has improved their health compared to those who decreased tobacco
use by 1.5 cartons or fewer per month (OR=4.35, 95% CI: 1.13–16.9; OR=25.67,
95% CI: 2.97–221.7, respectively).
CONCLUSIONS The majority of e-cig users perceived better health. Our findings
suggest that health campaign designers should carefully assess the scientific
uncertainty surrounding the use of these devices and consider means to clearly
convey this information. Given the lack of scientific agreement on the health
effects of e-cigs and the important role that perceptions play in behavior, health
campaign designers, health education practitioners, policy makers, and health
care providers should err on the side of caution when advising individuals about
e-cig use.
INTRODUCTION
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INTRODUCTION
The advent of electronic cigarettes (e-cigs) has
opened a potential new front in treatment and
addiction. Some tout the devices as a harm reduction
strategy that could promote smoking cessation in
millions of cigarette smokers1,2. Others view e-cigs

as a new pathway to nicotine addiction, especially for
countless adolescents and young adults3,4. Further,
concerns abound due to the potential for dual- or
poly-use (i.e. using e-cigs in combination with one
or more other tobacco products) as well as for the
non-smoking population to be drawn to e-cigs due
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to marketing claims suggesting that the products do
no harm. In a recent position statement5, the Forum
of International Respiratory Societies concluded
that: ‘potential benefits to an individual smoker
should be weighed against harm to the population
of increased social acceptability of smoking and use
of nicotine’. But other groups assert that e-cigs are
beneficial to public health because they provide
smokers with alternatives to tobacco, thereby
decreasing harmful effects6. Although use of e-cigs
may prove helpful to some combustible cigarette
smokers who are unwilling or unable to quit, or
to heavy smokers seeking to decrease the number
of cigarettes consumed, their overall usefulness
as a cessation tool or in reducing overall harmful
effects needs to be ascertained by further studies.
Competing recommendations, as well as emerging
scientific equivocal findings, have left health care
providers, policy makers, and health education
practitioners without clear guidance in formulating
recommendations to current smokers and individuals
interested in vaping.
Since e-cigs were introduced to the US
marketplace about a decade ago, adult awareness
and use of these products have been increasing.
For example, recent estimates suggest that over
four-fifths (83.6%) of adults were aware of e-cigs
and one-fifth (22.4%) had used an e-cig at least
once7. The perception that e-cigs have lower health
risks compared to combustible cigarettes has been
found also among adults 8-11. For example, one
study reported that among current adult smokers,
e-cigs were thought to have lower health risks than
combustible cigarettes, snus and dissolvable forms
of tobacco 10. Another found that nearly 60% of
dual users (i.e. combustible cigarettes and e-cigs)
believed that nicotine replacement therapy (which
is FDA approved) was as harmful as e-cigs11. Recent
evidence, however, suggests that views of the harm
perceptions of e-cigs compared to traditional tobacco
products may be shifting. According to one study in
2012, over half (50.7%) of study participants viewed
e-cigs as less harmful than combustible cigarettes;
however, by 2014, this decreased12 to 43.1%. Further,
some recent evidence suggests that between 2012
and 2015 more adults perceived e-cigs as posing
equal or greater harm than combustible cigarettes
(12.9% and 39.8%, respectively)13.

In line with the growing popularity of e-cigs,
there has been a proliferation of vape shops,
specialty retailers serving customers interested in
e-cigs. Despite the increase in vape shops, relatively
few studies have focused on vape shop patrons (e.g.
product perceptions, use patterns). Research with
vape shop customers in the US14 and Canada15 found
that these e-cig users tended to be current or former
smokers who used advanced equipment and viewed
vaping as a means to reduce or eliminate smoking.
Further, many vape shop customers perceived
e-cigs as being of relatively lower harm and even
beneficial to their health. A recent examination of
online vape shop customers yielded similar results16.
For example, the majority of these online purchasers
reported health benefits and, although some
perceived vaping as harmful, most viewed it as low
in harm (i.e. either not harmful or not particularly
harmful).
In this study, we explored the perceptions of
e-cigs held by vape shop customers in a geographic
area that historically has had favorable views and
higher use rates of traditional tobacco products.
We examined whether vape shop patrons believed
that their health is affected by the use of e-cigs and
whether such use has changed their consumption of
traditional tobacco products. We also characterize the
populations that perceive the most health benefits
of e-cigs. The purpose of this study was to evaluate
the association between e-cig use, change in tobacco
use, and perception of health.

METHODS
Study procedures
A cross-sectional survey of e-cig users was conducted
in 9 vape shops across Louisville, Kentucky, in 2015.
By sampling vape shops in different areas of the city
we hoped to capture a sample that reflected vape shop
customers across Louisville, not just the e-cig users
of one demographic and/or geographical part of the
city. After approval by the University’s Institutional
Review Board (IRB number 14.0493) and by the
vape shop owners, the survey was administered
during afternoon and evening business hours when
vape shops were at their busiest. Customers were
approached by a member of the research team and
asked to complete the questionnaire while in the
store.
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Survey methods
The questionnaire used in this survey was developed
by the investigators and consisted of 39 questions
about e-cig use, traditional tobacco use, perceptions
of health, and demographics. Questions were
adapted from the CDC National Adult Tobacco
Survey (NATS) questionnaire to capture tobacco
use behaviors. Vape shop customers and employees
who were at least 18 years old were invited to
complete the survey. Participants did not receive an
incentive payment and completed the questionnaire
in approximately 10 minutes while in the store.

(median=3 mL/day), assigning the overall median
amount of e-liquid to participants with missing
values is an acceptable approach. These questions
were used to calculate e-liquid (mL) used per month.

Statistical analysis
We used Fisher’s Εxact Τest and Wilcoxon Rank
Sum p-values to compare categorical and continuous
demographics and e-cig use behaviors between
participants who perceived that e-cig use has
improved their health and those who perceived that
their health was not affected.
Change in cigarette use was calculated (cigarettes/
month) and categorized into three groups based on
the distribution of the overall sample and standard
quantities of cigarettes in packages (20 cigarettes/
pack and 10 packs/carton). The categories for
change in cigarette use were less than 1–1.5
cartons/month, 2–3 cartons/month, and more than
3 cartons/month. Similarly, the quantity of e-liquid
used was calculated (mL/month) and categorized
into practical groups based on the standard quantity
commonly purchased in a bottle of e-liquid (30 mL/
bottle). The categories of e-cig use were less than or
equal to 3 bottles/month, 4–5 bottles/month, and
more than 5 bottles/month.
Logistic regression was used to assess the
association between change in tobacco use, e-cig use,
and perception of health effects. Odds ratios (OR)
with 95% confidence intervals (CIs) are reported for
crude models. SAS 9.4 (Cary, N.C.) was used for
analysis.

Measures and definitions
Perceived health effects of e-cig use were assessed
by the question: ‘In your opinion, how has using
e-cigarettes affected your health?’. Participants were
given the response options: ‘My health is better’,
‘My health is worse’, and ‘My health has not been
affected’. No participant selected ‘My health is
worse’, so the variable was dichotomized.
Questions about past and current tobacco use were
used to characterize participants’ perceived change
in tobacco use since vaping initiation. Participants
reported the number of cigarettes (all references
to participant cigarette use in this study refer to
combustible cigarettes) smoked per day, as well
as the number of days smoked per month for two
periods, corresponding to the present and prior to
using e-cigs. Responses to these four questions were
used to calculate the number of cigarettes smoked
per month before e-cig use and after becoming an
e-cigarette user. The number of cigarettes/month
before being an e-cig user was subtracted from
the number of cigarettes/month currently smoked
to obtain the perceived change in cigarette use
attributed to e-cig use.
E-cig use was characterized by questions about
quantity of e-liquid (mL) used per day and number
of days vaped in the past month. Participants who
did not indicate the quantity of e-liquid used per day
(n=8; Health better: n=3, Health not affected: n=5)
were assigned the study sample median amount. All
of the participants who did not report the quantity
of e-liquid used per day indicated spending less than
$ 125 per month on e-cigarettes and equipment.
Based on the quantity of e-liquid used by other
vape shop customers spending a similar amount

Sample characteristics
The overall study consisted of 80 participants, but two
were excluded from the analysis due to incomplete
survey data. Median age of participants (N=78)
was 27.5 years (min= 18, 25th percentile=22, 75th
percentile=39, max=58), 73.1% were male (n=57),
87.2% were Caucasian (n=66), and 71.8% were
single (n=56). The majority of participants (69.2%)
had attended at least some college (n=53), of which
41.5% obtained some type of college degree (n=22).
In terms of use patterns, 7.7% of participants (n=6)
used only e-cigs and had not smoked 100 cigarettes
in their lifetime; 78.2% (n=61) identified as former
smokers (i.e. smoked at least 100 cigarettes in their
lifetime, but reported not smoking at all during the
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past month); 11.5% (n=9) currently use cigarettes
‘some days’ or ‘every day’, and two did not respond
to these survey items. Approximately 76.9% (n=60)
of participants perceived their health as better with
e-cig use, whereas 23.1% (n=18) perceived their
health to be unaffected by e-cig use.
The comparison of demographic characteristics
between the two groups is presented in Table 1.
There was no significant difference in the median
age of those perceiving their health to be better
(median=30 years; min=18, 25th percentile=22,
75th percentile=39, max=58) and those perceiving
their health not to be affected (median=25 years;
min=18, 25th percentile=20, 75th percentile=39,
max=53). Significantly more males than females
perceived their health as better with e-cig use
(79.7% and 20.3%, respectively; p=0.04); however,
the overall sample of females was small (n=20).
There was no significant difference in age (p=0.61),

education level (p=0.70), marital status (p=0.56), or
overall perception of health (p=0.23) between the
two groups.

Table 1. Participant Demographics, Louisville,
Kentucky, USA, 2015 (N=78)

Association between change in tobacco use and
perception of health effects
The majority of participants were former or
current cigarette users (92.3%) with most of these
participants (n=31) smoking 21 or more cigarettes
per day before starting vaping. Participants who
perceived their health as better with e-cigarette

Health
Health is
not
better
affected
(n=18)
(n=60)
% (n)
% (n)
Gender
Female
Male
Education
High school graduate or GED
Some college
College degree (2-year, or
4-year, or professional)
Race
White/Caucasian
Black/African American
Hispanic/Latino
American Indian/Alaskan
More than one race
Marital Status
Single, never married
Single, divorced
Married or domestic partner
Belief about their health
Excellent
Good or very good
Fair

20.3 (12)
79.7 (47)

RESULTS
Association between e-cig use and perception of
health effects
The majority of participants used e-cigs ‘every day’ of
the month (Table 2). Overall, the amount of e-liquid
used per day ranged from 1 to 30 mL, with a median
of 4 mL (IQR=5.75). In addition, 30 participants
used 3 bottles or less of e-liquid per month, 24 used
4–5 bottles, and 24 used more than 5 bottles. Results
from logistic regression models demonstrate that
there is no significant association between quantity
of e-cig use and perceived effect of e-cig use on
health (comparing middle use to lowest: OR=1.54,
95% CI: 0.44–5.4; highest to lowest OR=3.0, 95% CI:
0.71–12.7).

p
0.04

44.4 (8)
55.6 (10)

Table 2. E-cigarette use behaviors, Louisville,
Kentucky, USA, 2015 (N=78 )

0.70
31.0 (18)
37.9 (22)
31.0 (18)

27.8 (5)
50.0 (9)
22.2 (4)

Health
Health is
not
better
affected
(n=18)
(n=60)
% (n)
% (n)

0.05ª
88.1 (52)
1.7 (1)
0 (0)
1.7 (1)
8.5 (5)

82.4 (14)
0 (0)
11.8 (2)
5.9 (1)
0 (0)
0.56

56.9 (33)
17.2 (10)
25.9 (15)

a

66.7 (12)
5.6 (1)
27.8 (5)
0.23

27.6 (16)
72.4 (42)
0 (0)

Days of e-cigarette use per
month
Every day
Less than every day
Amount of e-liquid used
(mL/day)
Median (Range)
Mean (SD)
Nicotine in e-liquid (mg/mL)
None
1–3
4–11
12–24

a

16.7 (3)
77.8 (14)
5.6 (1)

a Fisher’s exact test

93.3 (56)
6.7 (4)

83.3 (15)
16.7 (3)
0.23a

4.0 (1–30) 4.0 (1–18)
7.3 (7.1) 4.7 (4.1)
0.42
6.7 (4)
51.7 (31)
31.7 (19)
10.0 (6)

16.7 (3)
44.4 (8)
22.2 (4)
16.7 (3)

Significance at the p<0.05 level. a Wilcoxon rank-sum test p-value
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use were heavier smokers before starting vaping
compared to participants who perceived their health
as unaffected by e-cigarettes (Table 3).
The majority of participants indicated that they
do not currently smoke any cigarettes (88.5%). The
range of change in number of cigarettes used per
month, after vaping compared to before vaping,
was -35.5 to 0 with a median of -15.5 (IQR=17.5)
cigarettes per month. No participant reported an
increase in use of cigarettes since starting to use
e-cigs. After use of e-cigs started, 24 participants
decreased cigarette use by 1–1.5 cartons/month,

23 decreased use by 2–3 cartons/month, and
29 decreased use by more than 3 cartons/month.
Change in cigarette use was significantly associated
with the perception that health is better with e-cig
use. Participants who decreased cigarette use by
2–3 cartons/month and more than 3 cartons/month
after starting vaping were significantly more likely to
indicate that e-cig use has made their health better
compared to those who decreased tobacco use by
1.5 cartons or fewer per month (OR=4.35, 95% CI:
1.13–16.9; and OR=25.67, 95% CI: 2.97–221.7;
respectively).

Table 3. Tobacco use behaviors, Louisville, Kentucky,
USA, 2015 (N=78 )

DISCUSSION
This investigation evaluated the association between
e-cig use, change in traditional tobacco use, and
perception of health. The majority of participants
perceived their health to be better since starting e-cig
use. Previous work17,18 found that e-cig users report
health benefits, such as better asthma regulation,
easier breathing, less coughing, and more energy,
while our results provide additional evidence that
e-cig users perceive vaping as beneficial to their
overall health.
There was no association between e-cig use
behaviors or nicotine levels and perception of
health benefits. However, participants who reported
reductions in tobacco use since vaping were more
likely to report better health. Thus, the perceived
health benefits of vaping could derive from the
reduction in use of traditional tobacco products,
rather than from e-cig use directly. The majority
of e-cig users in this study reported a reduction in
cigarette use. This finding on reduction in cigarette
consumption parallels results of previous studies with
both in-person and online vape shop customers14-16.
Although the sample is small, some participants
who smoked fewer cigarettes did not report changes
in health in our study. The reasons shaping their
views are unclear, and such factors warrant future
research (which could range from perceptional
and attitudinal studies to investigations of specific
risks, such as cardiovascular, cancer and respiratory,
or assessments of genetic differences such as in
CYP2A6-deficient smokers).
Conclusions surrounding the positive and/or
negative effects of e-cigs are unclear and the longterm health effects are unknown. For example, a

Health
Health is
not
better
affected
(n=60)
(n=18)
% (n)
% (n)
Smoked 100 traditional
cigarettes or more/lifetime
Yes
No
Before you started vaping,
how many days in a month
did you usually smoke
traditional cigarettes?
Every day
Less than every day
Before you started vaping,
how many traditional
cigarettes did you typically
smoke in one day?
None
1–10
11–20
21 or more
Currently, how many days in
a month do you usually use
traditional cigarettes?
Every day
Less than every day
Currently, how many
traditional cigarettes do you
typically smoke in one day?
None
10 or fewer cigarettes
11–20 cigarettes
21 or more cigarettes

98.3 (59)
1.7 (1)

Fisher’s
exact
p
0.002

72.2 (13)
27.8 (5)
<0.001

96.7 (58)
3.3 (2)

52.9 (9)
47.1 (8)
0.002
0.002a
0.01b

1.7 (1)
16.7 (10)
35.0 (21)
46.7 (28)

29.4 (5)
23.5 (4)
29.4 (5)
17.7 (3)
0.03

1.7 (1)
98.3 (58)

17.7 (3)
82.4 (13)
0.13
0.20a

91.7 (55)
6.7 (4)
1.7 (1)
0 (0)

77.8 (14)
11.1 (2)
5.6 (1)
5.6 (1)

Significance at the p<0.05 level. a Fisher’s exact p-value for none vs any cigarettes
b Fisher’s exact p-value for none and 1–10 cigarettes vs 11–20 cigarettes and 21 or
more cigarettes.
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recent systemic review of work on the health effects
of e-cigs noted the frequency of contradictory
or inconsistent findings as well as several
methodological problems and conflicts of interest19.
Despite incomplete information on health effects,
increasing evidence regarding the potential toxicity
of the devices and liquids used in vaping is emerging.
One investigation showed that inhaled vape contains
7 of 9 potentially hazardous chemicals detectable
above a certain threshold and in exhaled vape 2 of
these 9 remained elevated20. Carbonyls, a potentially
toxic compound, are generated in e-cigs also 21,22.
Furthermore, studies suggest that levels of oxidants
or reactive oxygen species found in e-cigs may be the
same or higher than those in combustible cigarettes
when these items are disposed23 and recent results
revealed a buildup of plaque in mice, suggesting
increased cardiovascular risk from e-cig vapor24.
The current lack of supporting evidence for both
positive and negative health claims makes it difficult
to fully understand the health effects of e-cigs;
however, the perception that e-cigs are healthier
than combustible cigarettes is often perpetuated by
media, marketing, vape shops, and some public health
officials25. E-cigs are not harmless and their longterm effects are unknown; increased use patterns
in the US, in part, may be linked to the perception
that these products are healthier than combustible
cigarettes26. Increasing public understanding of the
current level of scientific knowledge through health
campaigns is important, as is educating frontline
workers such as vape shop employees on emerging
health findings to help them to better assist customers
with questions about use and consequences.

upon the experiences of other groups, such as
individuals who may have perceived health problems
from vaping and discontinued e-cig use and former
smokers who tried vaping but do not currently use
e-cigs; however, the perceptions and experiences
of such samples would be interesting to explore in
future research. Additionally, this study examined
e-cig users in one city; thus, our findings may not
be representative of e-cig users generally. Future
research could compare perceived health benefits of
e-cig use among dual (traditional tobacco and e-cig)
users and e-cig only users that previously used
traditional tobacco products.
Despite these limitations, the study has several
strengths and contributes to the literature on e-cig
use and perceptions. One strength is the focus on vape
shop patrons. Although purchases at these specialty
stores have burgeoned, few studies have focused on
examining the use patterns and views of vape shop
customers. However, much information can be
gleaned by examining this set of e-cig users. Another
strength of the study is the examination of e-cig use
in a geographical area where tobacco product use has
remained comparatively high and general positive
perceptions of tobacco products have been resistant to
change. Additionally, the research design connecting
health perceptions and changes in consumption at two
periods is of value. Even with these contributions,
much work remains still to be done to gain a clearer
picture of use patterns and health perceptions.
In summary, most of our participants believed that
their health had improved since they began vaping.
This research suggests that health campaign designers
and health practitioners should carefully assess the
scientific uncertainty surrounding the use of these
devices and consider means to clearly convey this
information. We found that when vaping is perceived
to have reduced tobacco use, people perceive e-cigs
as beneficial to their health. Future research into how
perceptions impact actual use behaviors is important
to understanding whether e-cigs replace traditional
tobacco use, lead to dual use, or involve as many (or
potentially more) harms as combustible cigarettes.

Limitations and contributions
Some limitations of our study need to be considered.
The sample size was relatively small due to the
low volume of customer traffic in some stores.
Another limitation was that tobacco and e-cig use
patterns were self-reported. Given that the study
was cross-sectional and decreases in smoking
cannot be verified, we cannot be certain participants
actually reduced cigarette use. In addition, recall
bias is possible, especially if participants desire to
be labeled former smokers rather than dual users.
Another limitation arises from the focus on e-cig
users. Given this focus, our study cannot comment

CONCLUSIONS
Our results indicate that the majority of e-cig users
perceived their health to be better since they began
to vape. We note that the perceived health benefits
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of vaping could derive from reported reduction in
tobacco use. Given the lack of scientific agreement
on the health effects of e-cigs as well as the important
role that perceptions play in behavior, health
campaign designers, health education practitioners,
policy makers, and health care providers should err
on the side of caution when advising individuals
about e-cig use. Additionally, vape shop employees,
due to their key roles in assisting e-cig customers,
are an important group to consider in future health
messaging efforts.
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